A detailed history of Homestead Advisers Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Homestead Advisers Corp holds 1,859,940 shares of RPRX stock, worth $52.5 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
1,859,940
Previous 1,892,540 1.72%
Holding current value
$52.5 Million
Previous $57.5 Million 14.67%
% of portfolio
1.22%
Previous 1.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$26.26 - $29.9 $856,076 - $974,740
-32,600 Reduced 1.72%
1,859,940 $49 Million
Q1 2024

May 10, 2024

BUY
$27.46 - $31.33 $15 Million - $17.1 Million
547,000 Added 40.65%
1,892,540 $57.5 Million
Q4 2023

Feb 13, 2024

BUY
$26.21 - $29.22 $65,525 - $73,050
2,500 Added 0.19%
1,345,540 $37.8 Million
Q3 2023

Nov 09, 2023

BUY
$26.26 - $31.38 $551,460 - $658,980
21,000 Added 1.59%
1,343,040 $36.5 Million
Q2 2023

Jul 25, 2023

BUY
$29.6 - $36.56 $198,320 - $244,952
6,700 Added 0.51%
1,322,040 $40.6 Million
Q1 2023

Apr 27, 2023

SELL
$32.77 - $39.4 $930,668 - $1.12 Million
-28,400 Reduced 2.11%
1,315,340 $47.4 Million
Q4 2022

Feb 03, 2023

BUY
$39.17 - $44.04 $15,668 - $17,616
400 Added 0.03%
1,343,740 $53.1 Million
Q3 2022

Nov 07, 2022

SELL
$39.88 - $44.65 $127,616 - $142,880
-3,200 Reduced 0.24%
1,343,340 $54 Million
Q1 2022

May 12, 2022

SELL
$37.46 - $42.44 $786,660 - $891,240
-21,000 Reduced 1.54%
1,346,540 $52.5 Million
Q4 2021

Feb 07, 2022

BUY
$35.17 - $42.48 $7.38 Million - $8.91 Million
209,700 Added 18.11%
1,367,540 $54.5 Million
Q3 2021

Nov 05, 2021

BUY
$36.14 - $42.24 $15.8 Million - $18.5 Million
437,600 Added 60.76%
1,157,840 $41.8 Million
Q2 2021

Aug 02, 2021

BUY
$39.85 - $46.63 $28.7 Million - $33.6 Million
720,240 New
720,240 $29.5 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $12.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Homestead Advisers Corp Portfolio

Follow Homestead Advisers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.